19.12.2023 15:00:00

CVS Health to present at the 42nd Annual J.P. Morgan Healthcare Conference

WOONSOCKET, R.I., Dec. 19, 2023 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that President and CEO Karen S. Lynch and Interim Chief Financial Officer Thomas F. Cowhey will participate in a fireside chat with investors at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024, at approximately 7:30 a.m. Pacific Time.

An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.

About CVS Health
CVS Health® is the leading health solutions company, broadening access to care for millions of people nationwide. We improve the health of communities across America through our local presence, digital channels and with over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. We support individuals with their health – whether that's managing health conditions, staying compliant with their medications or accessing affordable health services in the most convenient ways. Our goal is to create seamless connections across the health care system, simplifying the experience and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.

CVS Health logo (PRNewsFoto/CVS Health)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302018348.html

SOURCE CVS Health Corporation

Analysen zu CVS Health Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

CVS Health Corp 42,12 -1,30% CVS Health Corp